Hinge Health Inc. has evolved from a specialised digital musculoskeletal (MSK) clinic into an enterprise-scale, multi-condition virtual care provider. Central to this corporate expansion is an unconventional strategy within modern healthcare technology: pairing aggressive clinical labor automation with targeted acquisitions in therapeutic hardware to establish sustainable competitive moats. Following its initial public offering in May 2025 at $32 per share, the company's equ

The European healthcare technology, medical devices (Medtech) and artificial intelligence (Health AI) ecosystems have transitioned from post-pandemic venture fragmentation into a disciplined era of industrial maturity. Following a severe liquidity drought that curtailed capital deployment and delayed public listings between late 2021 and 2024, the public offering window is reopening under fundamentally altered underwriting standards. Institutional public equity allocators no